0001487371-21-000009.txt : 20210122
0001487371-21-000009.hdr.sgml : 20210122
20210122182551
ACCESSION NUMBER: 0001487371-21-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210120
FILED AS OF DATE: 20210122
DATE AS OF CHANGE: 20210122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maderazo Alan Baer
CENTRAL INDEX KEY: 0001811984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34753
FILM NUMBER: 21547369
MAIL ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GenMark Diagnostics, Inc.
CENTRAL INDEX KEY: 0001487371
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 272053069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (760) 448-4300
MAIL ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
wf-form4_161135793753010.xml
FORM 4
X0306
4
2021-01-20
0
0001487371
GenMark Diagnostics, Inc.
GNMK
0001811984
Maderazo Alan Baer
5964 LA PLACE COURT
SAN DIEGO
CA
92008
0
1
0
0
VP, Qual, Reg, & Clin Affairs
Common Stock
2021-01-20
4
S
0
5000
15
D
225899
D
Common Stock
2021-01-21
4
M
0
26825
0
A
252724
D
Common Stock
2021-01-21
4
M
0
21694
0
A
274418
D
Common Stock
2021-01-21
4
M
0
16666
0
A
291084
D
Market Stock Units
0.0
2021-01-21
4
M
0
26825
0
D
Common Stock
26825.0
0
D
Market Stock Units
0.0
2021-01-21
4
M
0
21694
0
D
Common Stock
21694.0
6667
D
Market Stock Units
0.0
2021-01-21
4
M
0
16666
0
D
Common Stock
16666.0
16667
D
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person on 7/28/2020.
The MSU's vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person was eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's three-year total Shareholder return, as compared to the Nasdaq Composite Index.
The MSU's vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's two-year total Shareholder return, as compared to the Nasdaq Composite Index.
Represents the target number of shares which remain subject to the award.
The MSU's vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's one-year total Shareholder return, as compared to the Nasdaq Composite Index.
/s/ Eric Stier, Attorney-in-fact
2021-01-22